Perrigo Company (PRGO -0.8%) says it's acquired the remaining stake of privately held Cobrek...
Friday, December 28, 2012, 3:18 PM ETPerrigo Company (PRGO -0.8%) says it's acquired the remaining stake of privately held Cobrek Pharmaceuticals, in a deal worth approximately $45 million on a cash-free and debt-free basis. PRGO has had a collaborative agreement with the company since 2008, after buying an 18% interest to develop and market Cobrek's foam dosage form generic pharmaceutical products.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles